eCite Digital Repository

A review of current treatment options for Glioblastoma Multiforme


Nichols, LJ, A review of current treatment options for Glioblastoma Multiforme, Australasian Journal of Neuroscience, 21, (2) pp. 1-7. ISSN 1032-335X (2011) [Refereed Article]

Restricted - Request a copy

Copyright Statement

Copyright 2011 ANNA (The Australasian Neuroscience Nurses Association)

Official URL:


Treatment options for most patients diagnosed with a Glioblastoma Multiforme consist of surgery, radiotherapy and chemotherapy. Despite recent advances treatments remains palliative and not curative. The life expectancy for patients is still dismal, and in this context, the objective should be towards improving not only quantity but also quality of life. The following paper is a critical review of the literature pertaining to the treatment of Glioblastoma Multiforme, focusing on the use of the two most available and utilised chemotherapy regimes. Specifically, the oral alkylating agent Temozolomide and surgically implanted polymer wafers impregnated with Carmustine (commonly known under the name of ‘Gliadel’).

Item Details

Item Type:Refereed Article
Keywords:Glioblastoma Multiforme treatment, Glioblastoma multiforme, Temozolomide, Gliadel, chemotherapy.
Research Division:Health Sciences
Research Group:Nursing
Research Field:Acute care
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Nichols, LJ (Mrs Linda Nichols)
ID Code:82644
Year Published:2011
Deposited By:Health Sciences B
Deposited On:2013-02-08
Last Modified:2013-06-26
Downloads:2 View Download Statistics

Repository Staff Only: item control page